Search for: "MYLAN PHARMACEUTICALS INC" Results 221 - 240 of 497
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jun 2012, 1:58 pm by Gene Quinn
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...]... [read post]
20 Jul 2018, 11:44 pm by Lawrence B. Ebert
The outcome:Mylan Pharmaceuticals, Inc., petitioned for interpartes review (“IPR”) of various patents owned by Allergan,Inc., relating to its dry eye treatment Restasis. [read post]
20 Sep 2017, 9:18 am by Christine A. Gaddis
Mylan Pharmaceuticals Inc., a patent infringement matter brought under the Hatch-Waxman statute and filed before the TC Heartland decision, the parties did not dispute that, in light of TC Heartland, the defendant, a West Virginia corporation, could not be said to “reside” in Delaware. [read post]
1 Mar 2013, 6:28 am by Gene Quinn
Related posts:Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
20 Jun 2008, 6:13 pm
The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. [read post]
3 Oct 2022, 8:27 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
12 May 2008, 8:59 am
Product Distributed by: Mylan Pharmaceuticals, Inc. under a "Bertek" LabelTherein, we are told that this Digitek recall, at least for Bertek tablets, goes back all the way to March 2006, more than two years before the April 2008 announcements by Actavis and the FDA:Mylan Pharmaceuticals Inc. is continuing a voluntary recall of the Actavis Totowa recall of Digitek ® (digoxin tablets, USP). [read post]